May 1, 2013
By:
Jill Wechsler
Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight.
|
April 1, 2013
By:
Jill Wechsler
Opioid abuse generates calls for efforts to curb distribution.
|
March 1, 2013
By:
Jill Wechsler
Vaccine development is benefiting from manufacturing advances.
|
February 1, 2013
By:
Jill Wechsler
Shortages spur efforts to overhaul manufacturing oversight.
|
January 1, 2013
By:
Jill Wechsler
Shortages spur efforts to overhaul manufacturing oversight.
|
December 1, 2012
By:
Jill Wechsler
White House and Congress likely to struggle over funding for bio/pharmaceutical regulation.
|
November 1, 2012
By:
Jill Wechsler
Manufacturing and in-depth characterization provide basis for demonstrating product equivalence.
|
October 1, 2012
By:
Jill Wechsler
User fees aim to speed approvals and support inspections.
|
September 1, 2012
By:
Jill Wechsler
Manufacturers and regulators struggle to control phony versions of crucial medicines.
|
|
